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1. Introduction 
Epilepsy is a chronic neurological disease involving recurring behavioral seizures, and 
affects approximately 1% of the worldwide population of humans and cats, and 2-3% of 
dogs. Epilepsy causes recurring behavioral seizures, which are transient behavioral changes 
caused by disordered, synchronized, and rhythmic firings of populations of neurons in the 
brain that propagate to regions connected with the first insult on the neural circuits, induced 
by abnormal neural plasticity (Browne and Holmes 2000). The seizure expression is induced 
by idiopathic/cryptogenic and remote symptomatic causes, as concrete examples, febrile 
illness in children younger than 16 years (Besli et al., 2010) and cerebrovascular and 
ethanol/drug-related accidents in adults. When the seizures are prolonged, or occur in a 
series, there is an increased risk of status epilepticus. About 15 % of persons with epilepsy 
experience status epilepticus, which induces more brain damage. It is known that large 
populations of epilepsy patients express status epilepticus due to medication changes in 
both children and adults. Hence, improving the compliance of patients to take medicine 
appropriately is very helpful to prevent the expression of status epilepticus.  
Despite the importance of medication, more than one third of patients with epilepsy are 
estimated to have pharmacoresistant epilepsy (Browne and Holmes 2000). Half of patients 
with refractory epilepsy are characterized as having mesial temporal lobe epilepsy (TLE) 
with foci in the amygdaloid complex, hippocampus, and surrounding cortex. To solve the 
problem of pharmacoresistance, it is important to clarify the molecular mechanisms 
involved in the development of pharmacoresistant seizures. Additionally, patients with 
epilepsy are at high risk of developing anxiety, depression, learning disorders, and sudden 
death (Dodrill, 1986; Franks, 2003; Motamedi and Meador, 2003; Sillanpää and Shinnar, 
2010). To improve the quality of life of patients, it is useful to clarify the comorbidity 
between seizures and other neuropsychiatry disorders. Depression and anxiety have the 
highest incidence in patients with TLE (Perini, et al., 1996). Hence, it should be clarified how 
the molecular signaling system regulates the development of pharmacoresistant abnormal 
neural plasticity and, as a result, recurring prolonged seizures that are induced by 
symptomatic causes. New drugs that can respond to seizures that known drugs fail to cure 
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should be developed based on the newly found signaling machinery. Many researchers 
have found molecular candidates responsible for seizure progression and the molecular 
mechanisms have been clarified little by little (Jia et al., 2011; Pitkänen and Lukasiuk, 2011). 
On the other hand, we have focused on clarification of the molecular mechanisms of 
epilepsy progression using a mesial TLE mouse model, amygdale kindled mice, showing 
epileptic seizures induced due to the development of abnormal neural plasticity in TLE 
regions. So far we have found three molecules responsible for epileptogenesis, a growth 
hormone, a sialyltransferase, and ganglioside GQ1b (Matsuhashi et al., 2003; Kato et al., 
2008; Kato et al., 2009). The clarification of signaling mechanisms with these molecules will 
resolve the pharmacoresistancy and open a path for therapeutic intervention for cases of 
anxiety and depression in the near future. 
2. Experimental animals 
2.1 Introduction of experimental animal models 
Several chronic models showing recurrent seizures have been developed as shown in Table 1.  
 
Stimulant   Chronic recurrent seizures References 
Physical  kindling  
Goddard et al., 1969; Racine et al., 
1972; Kato et al., 2001 
Chemical 
(metal) 
 alumina cream  Heinemann et al., 1986 
  cobalt Chang et al., 2004 
  ferric iron Willmore and Ueda, 2009 
Chemical 
(drug) 
 
pentylenetetrazol (Chronic 
schedule) 
Schallier et al., 2009 
  kainate Antonucci et al., 2009 
  pilocarpine  Pitkänen et al., 2011 
Inherited  EL mice  Fueta et al., 1983 
  DBA/2 mice (audiogenic) Seyfried and Glaser, 1981 
  SER rat Hanaya et al., 2010 
  Mongolian gerbil  Buchhalter 1993 
  targeted gene-deficient mice 
Puranam and McNamara, 1999; 
Meisleret al., 2001 
Table 1. Species of epileptic model animals (especially rodents). 
Physical (electro-stimulation): Kindling consists of the repeated administration of 
subconvulsive electrical stimulus to any of several brain regions, resulting in the 
development of EEG seizures (afterdischarges) and progressive behavioral seizures. When 
repeated stimuli are administrated into the amygdaloid complex and hippocampus, mesial 
temporal lobe epilepsy (MTLE), which is the cause in one-half patients with refractory 
epilepsy, is induced as eventual secondary generalized grand mal seizures. The kindling 
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model provides better insights into how abnormal neural plasticity is altered and newly 
acquired during epileptogenesis. Furthermore, when the number of grand mal seizures 
increases, status epilepticus is also caused in kindled mice. We therefore focused on kindling 
to clarify the molecular mechanisms of epileptogenesis and the occurrence of status 
epilepticus. 
Chemical (metal): When alumina cream is applied to the cerebral cortex of monkeys and 
cats, chronic spontaneous seizures are induced, however, the seizures subside after several 
months to years (Heinemann et al., 1986). Investigating the mechanisms of the termination 
of seizure expressions might provide clues to end refractory epilepsy. Implantation of cobalt 
into the cerebral cortex easy induces focal and secondarily generalized seizures in rodents, 
however, cobalt metal causes a large area of cortex to be lost, while the hippocampus 
containing the dentate gyrus appears intact (Chang et al., 2004). Microinjection of ferric ions 
into the rodent brain results in chronic recurrent seizures, which are brain injury responses 
induced by hemorrhage and free radical reactions observed in human posttraumatic 
epilepsy (Willmore and Ueda, 2009). 
Chemical (drug): Status epilepticus model mice are prepared with pentylenetetrazol (PTZ), 
kainate, and pirocarpin. PTZ-induced seizures: injection of PTZ (43 mg/kg) into the 
peritoneal cavity of 4-week-old mice 3 times per week for 4 weeks induced stereotyped 
spontaneous seizures (unpublished procedure). Kainate-induced seizures: an infusion of 
kainate (1 nmol/0.5 ฀µl) into the hippocampus of 8-week-old mice induces status epilepticus 
about 20 days after infusion (unpublished procedure; Antonucci et al., 2009). Pirocapine-
induced seizures: pirocarpine (100 mg/kg) is injected into the peritoneal cavity every 20 min 
until onset of status epilepticus (Elliott et al., 2003). SE induced with kainate and pirocarpine 
accompanies hippocampal damage, which seems to mimic human hippocampal atrophy. 
Additionally, the concentration of each drug should not be over the adequate dosage, as 
mice die immediately following the appearance of seizures. 
Spontaneous and genetic manipulation: EL mouse: tonic-chronic seizures appear when a 
mouse is tossed to height of 10 cm 10 times a day for 2-3 weeks (unpublished procedure; 
Fueta et al., 1983). Audiogenic seizure model of DBA/2: audiogenic seizures appear when a 
3-week-old mouse receives one 60-sec exposure to a pure tone sound (120 db) (Seyfried and 
Glaser, 1981). SER rat: rats homozygous for both zitter (zi) and tremor (tm) autosomal 
recessive mutations shows spontaneous epileptic seizures involving hippocampal atrophy 
in the CA3 subfield, in addition to many vacuoles in the brain (Hanaya et al., 2010). Gerbils 
with hypoplasia of the basilar artery circle suffer chronic seizures by a sudden change of 
circumstances (Buchhalter 1993). On the other hand, many one-gene-deficient mice have 
been produced with epileptic seizures, in which it is suggested that several channel gene 
deficient-dependent seizures mimic idiopathic seizures (Puranam and McNamara, 1999; 
Meisleret al., 2001). 
2.2 Preparation of kindled mice 
Figure 1 shows the dorsal side of the head (B) and the coronal section of the brain (C) in 
kindled mice with a microinjection cannula. All procedures were performed according to 
the guidelines for animal welfare of Osaka Prefecture University and Kyoto Sangyo 
University, and approved protocols. Surgical procedures were conducted under anesthesia 
with isoflurane (Dainippon Sumitomo Pharma Co. Ltd., Osaka, Japan) and Escain (Mylan 
Inc., Osaka, Japan) as described previously (Kato et al., 2001). Positions of brain regions 
were determined according to the stereotaxic coordinates shown by Paxinos and Franklin  
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Fig. 1. Photos show free-moving mice receiving kindling stimulation, E.E.G. recording, and 
microinjection (A) and views showing positions of electrodes and microinjection cannula (B 
and C). Views showing the dorsal side of the head (left) and a coronal section of the brain 
(right) in kindled mice with a microinjection cannula (A). In (A), Stim., stimulation; E.E.G., 
electroencephalographic; cannula, microinjection cannula transplanted into the 
hippocampus.  
(2001). Unipolar cathode electrode; made of tungsten steel and 0.1 mm in width (Inter 
Medical Co. Ltd., Nagoya, Japan), and an anode electrode; made of a screw and 1.0 mm in 
width and 3.0 mm in length (Biotex Kyoto, Japan), were implanted on the right side of the 
basolateral amygdaloid complex (A -2.0, L 3.0, V 4.5 mm from bregma; a) and on the left 
side of the subdural space (A 2.0, L 1.5 mm from bregma; b), respectively. Ten days after 
surgery, unrestrained conscious mice received a biphasic square wave pulse [480 µA; 60 Hz, 
200 µs duration, for 2 sec] using an electrical stimulator (SEN-3301; Nihon Kohden, Tokyo, 
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Japan) and isolator (SS-202J) once a day. Electroencephalographic (EEG) recordings were 
carried out with bilateral electrodes of the subdural space (b and c) prior to and after 
stimulation using PreAmp and Head Amp (BEMCT-21 and BH-3, Low cut = 0.5, High cut = 
30; Biotex, Kyoto, Japan) and the data acquisition program SleepSign ver.2.0 (Kissei Comtec 
Co. Ltd., Nagano, Japan). Seizures were monitored with a modified classification of Racine's 
criteria (Racine 1972) and the duration of afterdischarge and freezing was added to the 
behavioral criteria as described previously (Kato et al., 2001): stage 1, plus mouth and facial 
movement; stage 2, plus forelimb clonus and duration of afterdischarge greater than 5 sec; 
stage 3, plus forelimb clonus and duration of freezing greater than 15 sec; stage 4, plus tonic 
clonic seizures and tail up; stage 5, plus falling over. After reaching stage 5, mice were used 
in experiments as fully kindled mice following more stimulation for only 3 days. The brains 
of the mice were removed after decapitation within 2 hrs of the last kindling stimulation. 
The sham-operated mice were not stimulated but otherwise treated identically in all 
respects. 
2.3 Microinjection of drugs into the brains 
To observe the effect of drugs during epileptogenesis, a microinjection cannula (ID=0.2 mm; 
Eicom Corp., Kyoto, Japan) with a guide cannula (ID = 0.4 mm, OD = 0.5mm; Eicom Corp.) 
was also implanted on the left side of the hippocampus (A –2.0, L 1.5, V 2.5 mm; d in Fig. 1B 
and C) at the time of surgery to prepare kindled mice (Kato et al., 2009). 
One microliter of genotropin (1 µl of 540 pmol/µl; Faizer, Tokyo, Japan), pegvisomant (90 
pmol/µl, antagonist, Faizer) and buffer (40 mg/ml D-mannitol, 2 mg/ml glycine, and 0.02 
mM sodium phosphate, pH 6.85); and 1 µl octreotide acetate (1 µl of 90 pmol/µl; Novartis, 
Tokyo, Japan) and buffer (45 mg/ml D-mannitol, 3.4 mg/ml lactic acid in NaHCO3, pH 4.5) 
were injected into the hippocampus of unrestrained conscious mice (d in Fig. 1B) at a flow 
rate of 0.5 µl /min using a microsyringe pump (KDS 200 series; KD Scientific) according to 
the schedule described in Fig. 3A, in which we administered drugs every other day 7 times 
in total before and during epileptogenesis, respectively. Concentrations of the drugs applied 
to mice were determined based on the weight of drugs per weight of human patients. Mice 
received a biphasic square wave pulse 30 min following the microinjection. Statistical tests 
were mainly performed using a combination of Excel and Statview-J 5.0. Additionally, one 
microliter each of genotropin octreotide acetate, and pegvisomant (antagonist, recombinant 
protein, 12 mg/ml; Pfizer) was injected into the hippocampus of respective mice without 
kindling stimulation. Pegvisomant was used to investigate whether it affected the functions 
of endogenous GH in the brain. 
3. Differential expressions during epilepsy progression and following status 
epilepticus 
Reports have indicated gene expression patterns during and following epileptogenesis and 
the development of status epilepticus induced in rodents with drugs and electro-stimulation 
(Nedivi et al., 1993; Tang et al., 2002; Becker et al., 2003; Elliott et al., 2003; Lukasiuk et al., 
2003; Gorter et al., 2006). They have found several promising new anti-epileptogenic targets, 
for example, previous studies have indicated common immediate early genes including 
SER-regulated genes (Becker et al., 2003; Gorter et al., 2006) and prostaglandin-endoperoxide 
synthase 2 (Ptgs2, Cox-2) (Gorter et al. 2006; Ristori et al. 2008) as candidates for genes 
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causative of epileptogenesis. While inhibition of Cox-2 reduces epileptiform bursting in the 
hippocampus slice (Ristori et al., 2008), the inhibitor had no effect on epileptogenesis or 
spontaneous seizures in vivo (Holtman et al., 2009). This contradiction suggests that the roles 
of Cox-2 should also be studied in epilepsy. It was also reported that the expressions of 
hormone genes, such as galanin (Lerner et al., 2008; Mitsukawa et al., 2008), neuropeptide Y 
(Shannon and Yang, 2004; El Bahh et al., 2005; Silva et al., 2005), leptin (Shanley et al., 2002), 
and somatostatin (Monno et al., 1993; Buckmaster et al., 2002) were up-regulated in the brain 
following epileptogenesis and showed anti-epileptic effects. On the other hand, candidate 
genes associated with human epilepsy have been nominated in the HuGE database (Jia et 
al., 2011). More recent experimental research has shown the effect of antiepileptic drugs on 
differential gene expressions and antiepileptogenic behaviors (Pitkänen and Lukasiuk, 
2011). 
In the present review, we introduce growth hormone signaling as a candidate molecular 
system associated with epileptogenesis. We have screened differential gene expressions in 
the brain regions during kindling epileptogenesis by genechip array. As a result, we have 
identified growth hormone (GH), increasing the gene expression in the brain regions that 
kindling stimuli propagate from the basolateral amygdala during epileptogenesis (Fig. 2). 
On the other hand, the present amygdala kindled mice also indicated up-regulated 
expressions of SER-regulated genes (Kato et al., 2009) and the Cox-2 transcript (Fig. 4) 
following kindled seizures. 
4. Research 
4.1 Growth hormone signaling system 
Differential expressions of the GH transcript that increases in the brain during and 
following kindling epileptogenesis (Fig. 2) have been confirmed using a quantitative real-
time polymerase chain reaction-based analysis of mRNA (qRT-PCR) and Western blot 
analysis (Kato et al., 2009). Next, we investigated the distribution of the GH transcript in the 
brain to know whether the transcript is expressed in regions where the kindling-stimuli 
propagate in amygdala-kindled mice using in situ hybridization (Kato et al., 2009). Neuronal 
cells were typically oval with cRNA signals of GH in the regions, in which GH mRNA was 
expressed moderately in the brain, particularly around the limbic area containing the 
piriform cortex, the anterior thalamic nucleus, and the hippocampus. Previous studies of 
neural connections have already clarified that amygdala kindling leads more easily to the 
propagation of stimuli to the hippocampus→anterior thalamus→apical cortex involving the 
cingulate through neural connections (Meibach and Siegel 1977; Amaral and Witter 1995; 
Price 1995; Gemmell and O'Mara 2002). Thus, it was suggested that regions of the brain that 
express GH could be involved in the propagation of stimuli in neural circuits during 
epileptogenesis. 
To compare mRNA levels, total RNA was prepared from the apical part of the cerebral 
cortex (yellow circle), thalamus, (green circle), and the caudal part of the cerebral cortex 
[which includes posterior hippocampus, amygdaloid complex, temporal lobe] (red circle) of 
kindled, intermediate stage 3, and sham-operated mice. GeneChip array shows up-
regulation of GH transcript during epileptogenesis (A). Means and S.E.M. were calculated 
based on raw signal intensities (MG430_Scal_Signal) compensated by signal intensity with 
GAPDH control probes on the Mouse Genome 430 2.0 Array of the Affymetrix Genechip. 
There were significant differences of GH expression using Kruskal-Wallis tests of Kyplot 4.0: 
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in the apical cortex (x70.6, **p<0.01), the thalamus (x54.4, **p<0.01) and caudal cortex (x23.2, 
*<0.05) between sham-operated and full-kindled mice. 
 
 
Fig. 2. Comparisons of expression levels of Gh between full-kindled, intermediate stage 3, 
and sham-operated mice using genechip array. To compare mRNA levels, total RNA  
was prepared from the apical part of the cerebral cortex (yellow circle), thalamus,  
(green circle), and the caudal part of the cerebral cortex [which includes posterior 
hippocampus, amygdaloid complex, temporal lobe] (red circle) of kindled, intermediate 
stage 3, and sham-operated mice. GeneChip array shows up-regulation of GH  
transcript during epileptogenesis (A). Means and S.E.M. were calculated based  
on raw signal intensities (MG430_Scal_Signal) compensated by signal intensity  
with GAPDH control probes on the Mouse Genome 430 2.0 Array of the Affymetrix 
Genechip. There were significant differences of GH expression using Kruskal-Wallis  
tests of Kyplot 4.0: in the apical cortex (x70.6, **p<0.01), thalamus (x54.4,  
**p<0.01), and caudal cortex (x23.2, *<0.05) between sham-operated and full-kindled  
mice.  
To investigate whether GH has distinct roles in epileptogenesis, we injected genotropin 
(human GH recombinant, rGH) and octreotide, which is a somatostatin analog reducing 
secretion of GH (Lamberts 1987) into the hippocampus according to the schedule described 
in Fig. 3A. First, the administration of rGH resulted in a significant enhancement of 
epileptogenesis compared to the control as a whole (two-way factorial ANOVAs in Fig. 3C) 
and an increased number of spikes in afterdischarge following epileptic seizures (two-way 
factorial ANOVAs in Fig. 3B). Second, the progression of behavioral changes during 
epileptogenesis was attenuated (two-way factorial ANOVA in Fig. 3E); however, there were 
no differences in the number of spikes and duration of afterdischarges (Fig. 3D). This 
suggests that growth hormone causes the afterdischarge threshold to decrease during 
epileptogenesis. 
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Fig. 3. Effect of genotropin and octreotide on epileptogenesis (adapted from Kato et al., 
2009). Schedules of injection (A) of genotropin (1 ml of 540 pmol/ml, red circles in B and 
4C), octreotide acetate (1 ml of 90 pmol/ml, blue circles in D and E), and their buffer (1 ml, 
black circles in B-E) or kindling stimulation are shown. Stimulation was started from 
number 1 and continued to the 17th day. The number of spikes in afterdischarges on 
electroencephalograms (EEGs) are shown (B and D). Transition of stages (C and D). Means 
and S.E.M. for the two characteristics of mice with or without drugs following stimulation 
on each day were evaluated with two-way factorial ANOVA, which showed differences in 
mice with or without in B to E (Kato et al., 2009). The data for days when mice received 
stimulation were compared between injections of drugs and the buffer (Mann-Whitney U-
test: *p<0.05, **p<0.01). Administration of the hormone into the hippocampus markedly 
enhanced the progression of kindling, and the number of spikes during afterdischarges 
increased in mice following development of tonic-clonic convulsion. On the other hand, the 
administration of an inhibitor of its secretion into the hippocampus elicited a delay in 
progression. 
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As we have demonstrated the effect of GH on the brain during epileptogenesis, we next 
investigated whether the presence of GH induced GH signaling in the brain during 
epileptogenesis. As a method of investigation, we determined whether GH regulated the 
expressions of seizure-responsive genes directly in the brain. Finally, when the 
hippocampus was exposed to rGH for 24 hrs without kindling stimulation, rGH induced 
significant differential expressions of Egr1 mRNA (Kato et al., 2009), but not Cox-2 mRNA 
in the caudal cortex containing the hippocampus and amygdaloid complex (Fig. 4, result 
experimented by Mr. M. Suzuki). Both Egr1 and Cox-2 mRNAs were seizure-responsive 
genes in our kindling system. These relative results show that exogenous rGH induced an 
increase of Egr1 mRNA directly at least downstream of GH signaling, while Cox-2 
transcripts were not regulated by GH signaling. It has been reported that Cox-2 inhibitor  
 
 
Fig. 4. Effects of kindled seizures (A) and rGH microinjections (B) on expression levels of 
Cox-2 (prepared by M. Suzuki). Isolation of RNA and real-time RT-PCR followed the 
methods described previously (Kato et al., 2009). Quantitative PCR of Cox-2 mRNA was 
performed with SYBR Green (Power SYBR Green PCR Master Mix, Applied Biosystems) 
using a 7300 Real-Time PCR system. Primer pairs used for the PCR were: 5’- GAT CAT CAA 
TAC TGC CTC AA -3’/5’-CAG CTC AGT TGA ACG CCT TT-3’ (Cox-2, 184 bp, 1729-1912bp 
in NM_011198). The bar graph (mean + S.E.M.) shows the ratio of Cox-2 mRNA relative to 
GAPDH mRNA between sham-operated (n=10), stage 3 (n=8), and full-kindled (n=10) mice 
in the cerebral cortex containing the hippocampus and amygdala using the Kruskal-Wallis 
test [Steel-Dwass test]: *p<0.001, [kindling/stage 3 (between kindling and stage 3), *5p<0.01; 
kindling/sham, *4p<0.01]. Another bar graph shows the ratio of these transcripts in the 
caudal part of the cerebral cortex containing the hippocampus and amygdala with the 
administration of rhGH (n=4), pegvisomant (n=4), and the buffer (n=4) using the Kruskal-
Wallis test: p=0.981. There was no difference in Cox-2 transcripts among drug 
administrations.  
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has little effects on epileptogenesis or spontaneous seizures (Holtman et al., 2009), which 
also suggests that Cox-2 does not function under GH signaling. 
GH regulates physiological processes, including carbohydrate and lipid metabolism as well 
as somatic growth and development, therefore, it is possible that epileptogenesis is 
correlated with the differential expression of carbohydrates and lipids. Next, we screened 
the differential expression of gangliosides during epileptogenesis.  
4.2 Effect of ganglioside expressions 
A crude ganglioside mixture was prepared with extracts of the hippocampus dissected from 
adult mice following kindled seizures, and high performance thin-layer chromatography 
(HPTLC) analysis was performed according to previous reports (Iwamori and Nagai, 1981). 
The signal intensity of each ganglioside developed on the HPTLC plate was calculated in 
individual mice (6 kindled and 6 sham-operated mice) using PDquest software (Bio-
rad,Tokyo, Japan) and analyzed using a combination of Excel and Statview-J 5.0. The analysis 
demonstrated a decrease of GM1 and increase of GQ1b following kindled seizures (Kato et al., 
2008). The increase of GQ1b in the hippocampus following kindled seizures was confirmed by 
immunofluorescence with anti-GQ1b antibody. Taken together, the level of endogenous GQ1b 
increased following seizures in amygdaloid kindled mice, suggesting that the contents of 
GQ1b in the hippocampus are subject to epileptogenesis regulated by GH signaling. 
5. Conclusion 
We first found that GH plays distinct roles in epileptogenesis in the limbic system of the 
brain via GH signaling. While it was reported that GH is involved in lipolysis and has an 
effect that opposes that of insulin in the peripheral tissues (Scacchi et al., 2003), the present 
kindled seizures up-regulated the expressions of GQ1b in the brain. Given that 2-deoxy-D-
glucose (2DG) increases the afterdischarge threshold (Garriga-Canut et al. 2006) and the 
present kindled-seizures cause up-regulation of the expressions of an enzyme related to 
carbohydrate transition,฀α2,3-sialyltransferase (ST3Gal IV), in the hippocampus and 
thalamus (Okabe et al., 2001; Matsuhashi et al., 2003). Hence, we propose that metabolic 
regulation by GH signaling adjusts the afterdischarge threshold during epileptogenesis. We 
have developed ST3Gal IV gene-deficient mice and are studying the involvement of ST3Gal 
IV in epileptogenesis. The relevance of GH signaling, sialylation, and lipid metabolism in 
the progress of epilepsy should be clarified in the near future. 
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